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The unique family of receptors known as chemokine 
“scavenging receptors” was originally defined by their ability 
to ligate chemokines in a non-signaling fashion. These decoy 
receptors include chemokine receptor 6 (D6), the Duffy 
antigen receptor for chemokines (DARC), and CCX-CKR. 
The best described of these is D6, known to be expressed 
in placenta [1] and lymphatic endothelial cells [1,2] (in gut, 
skin, and lung) and capable of scavenging more than 12 
chemokines—mostly agonists of inflammatory CC chemo-
kine receptors from CCR1 to CCR5 [1]. Thus, in contrast 
to conventional chemokine receptors by which chemokine 
ligation induces leukocyte recruitment in inflammation, 
ligation via D6 leads to targeted chemokine degradation and 
consequent reduction of their bioavailability [2-4]. Consistent 
with this, the absence of D6 expression has been associated 
with uncontrolled and sustained inflammation in multiple 
inflammatory models, including mycobacterium tuberculosis 
infection, phorbol esters–induced cutaneous inflammatory 
response, and inflammatory bowel disease [3,5-7]. This has 
led to the theory that expression of D6 by lymphatic endo-
thelial cells plays a crucial role in mediating resolution of 
inflammation.
Recent data indicate that in addition to lymphatic endo-
thelial cells, various populations of immune cells, including 
B cells, macrophages, and dendritic cells, express the D6 
chemokine receptor [8-12]. Interestingly, and in contrast to 
its function when expressed in the lymphatic endothelium, 
D6 expression on leukocytes has been reported to promote 
inf lammatory responses in some experimental models 
[8,9,12-14]. One key report came from Liu et al., who demon-
strated that D6−/− mice develop milder forms of experimental 
autoimmune encephalomyelitis compared to their wild-type 
(WT) counterparts, which was mediated by an impaired 
T-cell response [14]. Thus, an alternate role for D6 via 
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Purpose: To identify the role of chemokine receptor 6 (D6) expression by dendritic cells (DCs) and its role in corneal 
transplant immunity.
Methods: Flow cytometry analysis was used to assess the expression level of the D6 chemokine receptor in different 
leukocyte populations and DC maturation following lipopolysaccharides (LPS) stimulation of bone marrow–derived 
DCs isolated from wild-type (WT) or D6−/− mice (C57BL/6 background). Mixed-lymphocyte reactions and delayed-type 
hypersensitivity assays were performed with bone marrow–derived DCs from WT or D6−/− mice to evaluate T-cell al-
loreactivity. Adoptive transfer experiments with T cells from WT or D6−/− hosts with BALB/c corneal allografts were 
performed. Graft opacity was assessed over an 8-week period, and graft survival was plotted using Kaplan–Meier 
survival curves.
Results: Expression of the D6 chemokine receptor was significantly higher in DCs compared to other leukocyte subpopu-
lations, including neutrophils, lymphocytes, and monocytes/macrophages. LPS challenge of D6−/− bone marrow–derived 
DCs elicited significantly lower levels of major histocompatibility complex II and costimulatory molecules (CD40, 
CD80, and CD86) compared to WT bone marrow–derived DCs, indicating the role of the D6 chemokine receptor in DC 
maturation. Further, DCs isolated from D6−/− mice induced less T-cell proliferation (p≤0.001) and interferon-gamma 
production in T cells of draining lymph nodes compared to WT mice following corneal transplantation (p≤0.001). More-
over, adoptively transferred T cells from D6−/− corneal transplanted mice to WT mice led to impaired graft rejection, 
compared to the hosts that received T cells from the WT transplanted mice.
Conclusions: We demonstrated D6 chemokine receptor expression by DCs and identified its critical function in multiple 
aspects of DC biology, including maturation and consequent elicitation of alloreactive T-cell responses that are respon-
sible for corneal allograft rejection.
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leukocyte expression that potentially involves the elicitation 
of adaptive responses has been suggested.
In the current study, we examined the specific function 
of D6 expression on corneal allograft rejection, which is 
mediated primarily by alloreactive CD4+ T cells. We accom-
plished this by using the T-cell adoptive transfer assay, simi-
larly described by Liu et al. [14], using D6−/− mice in corneal 
transplantation to evaluate the effect of D6 absence on 
immune rejection. Here, we demonstrate that host D6 expres-
sion actually amplifies alloreactive T-cell responses that 
mediate immune rejection. Furthermore, we have identified 
a positive contribution of D6 expression to DCs promoting 
their maturation, including upregulation of major histocom-
patibility complex (MHC) II and costimulatory (CD80/86, 
CD40) molecules. Taken together, our data identify a novel 
role for D6 in mediating alloimmune responses by promoting 
the maturation of dendritic cells (DCs) and allosensitization.
METHODS
Animals: Male 6- to 8-week-old C57BL/6 and BALB/c mice 
(Taconic Farms, Germantown, NY) were used. C57BL/6 D6 
null mice were kindly provided by Dr. Donald Cook (NIH/
NIEHS) and bred in house at the Schepens Eye Research 
Institute (Boston, MA) animal facility. The institutional 
Animal Care and Use Committee approved all procedures. 
All animals were treated according to the Association for 
Research in Vision and Ophthalmology Statement for the Use 
of Animals in Ophthalmic and Vision Research.
Flow cytometry: The following antibodies (Abs) were used: 
fluorescein isothiocyanate (FITC)-conjugated rat anti-mouse 
CD11b (monocyte/macrophage marker), FITC-conjugated 
hamster anti-mouse CD11c (dendritic cell marker), allophy-
cocyanin (APC)-conjugated rat anti-mouse CD45 (leukocyte 
common marker), FITC-conjugated hamster anti-mouse 
CD80 (costimulatory molecule, B7–1), FITC-conjugated 
rat anti-mouse CD86 (costimulatory molecule, B7–2), 
FITC-conjugated rat anti-mouse GR-1 (neutrophil marker), 
FITC-conjugated rat anti-mouse CD8, Phycoerythrin (PE)-
conjugated mouse anti-mouse IAb (major histocompat-
ibility complex class II), and goat anti-mouse D6 (Abcam, 
Cambridge, MA). Secondary Abs were rhodamine-conjugated 
donkey anti-goat immunoglobulin G (IgG), FITC-conjugated 
donkey anti-rabbit IgG, and FITC-conjugated goat anti-rabbit 
IgG. All primary and secondary Abs (except where noted) 
and isotype matched controls were purchased from BD 
PharMingen (San Diego, CA). To avoid non-specific staining, 
cells were blocked with anti-FcR mAb (CD16/CD32) for 15 
min at 4 °C before they were stained with primary antibodies 
or isotype-matched control antibodies (BD PharMingen).
Cultivation of bone marrow–derived dendritic cells: Bone 
marrow–derived DCs were generated as described elsewhere 
[15]. Briefly, 6- to 8-week-old WT or D6−/− mice were scari-
fied. The femurs were collected, and bone marrow cells were 
flushed with 28G syringes and seeded (2×106) in 10 ml Petri 
dishes with cultured medium (RPMI-1640 supplemented 
with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/
ml of penicillin, 100 µg/ml of streptomycin, 50 mM 2-ME) 
containing 20 ng/ml of granulocyte-macrophage colony 
stimulating factor (GM-CSF; PeproTech, Rocky Hill, NJ). On 
days 3 and 6, new medium containing GM-CSF (20 ng/ml) 
was added, and non-adherent and loosely adherent immature 
DCs were collected on day 8. To induce maturation, 100 ng/
ml of lipopolysaccharides (LPS; R&D Systems, Minneapolis, 
MN) was added 24 h before the cells were harvested.
Mixed leukocyte reaction: CD90+ splenic T cells (105/well) 
from BALB/c mice were MACS sorted (Miltenyi Biotec, 
Auburn, CA) and cocultured at 1:1 with mitomycin C–treated 
(50 μg/ml for 30 min at 37 °C; Sigma-Aldrich, St. Louis, 
MO) bone marrow-derived dendritic cells (BMDC) or splenic 
antigen presenting cells (APC; CD90-) for 4 days in 96-well 
round-bottom plates. After 3 days, the bromodeoxyuridine 
(BrdU) reagent (Sigma-Aldrich) was added for approximately 
16 h. Then, the plates were centrifuged, and the medium was 
removed. Following fixation and denaturation of each well, 
the plates were washed and incubated with peroxidase-anti-
BrdU conjugate solution at room temperature for 60 min. 
After washing, the horseradish peroxidase substrate was 
added, and optical density (OD) was analyzed at 450 nm 
using a microplate reader (MRX, Dynatech, Chantilly, VA).
Local adoptive transfer assay: BALB/c mice received a 
subcutaneous injection into the nape of the neck containing 
C57BL/6 splenocytes (105). After 7 days, lymph node (LN) 
T cells (105) from these mice were coinjected at a 1:1 ratio 
with WT or D6−/− BMDCs into the ear pinnae of the naïve 
BALB/c mice. Local adoptive transfer (LAT) assay was also 
performed with T cells from the C57BL/6 WT or D6−/− mice 
3 weeks post-transplantation with BALB/c donors. T cells 
(105) were coinjected at a ratio of 1:1 with BALB/c APCs 
into the ear pinnae of naïve C57BL/6 mice. LAT assays were 
performed twice, and each group consisted of n=5 mice. In 
both LAT assays, ear thickness was measured 48 h after cells 
were injected in a masked fashion using a micrometer (Mitu-
toyo; MTI, Paramus, NJ) [16].
Corneal transplantation and adoptive transfer: The corneal 
transplant protocol we used here has been described else-
where [16]. Briefly, the central cornea (2 mm diameter) was 
marked by a trephine and excised from a BALB/c or C57BL/6 
donor mouse using Vannas scissors (Storz Instruments, San 
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Dimas, CA), and then placed on ice in Optisol-GS (Bausch 
and Lomb, Rochester, NY). The graft bed was prepared by 
excising a 1.5-mm site in the central cornea of a C57BL/6 WT 
or D6−/− recipient mouse. A donor button was then placed onto 
the graft bed and secured with eight interrupted 11–0 nylon 
sutures (Sharpoint, Reading, PA). For the adoptive transfer 
experiments, splenic and draining lymph node T cells were 
isolated from D6−/− or WT mice 3 weeks after transplantation 
with BALB/c cornea, and 1×106 T cells were injected intra-
venously into C57BL/6 WT transplanted (BALB/c cornea) 
mice. Graft survival was evaluated twice a week over the 
course of 8 weeks using a slit-lamp biomicroscope. Experi-
ments were performed twice with five mice per group. We 
used the following standardized opacity-grading (ranges 
0–5+): 0=clear graft; 1+=minimal superficial (nonstromal) 
opacity; 2+=minimal deep stromal opacity; 3+=moderate 
deep stromal opacity; 4+=intense deep stromal opacity; 
5+=maximum stromal opacity. Rejection is defined as a score 
of 2+ or greater for two consecutive examinations.
Cauterization-induced corneal inf lammation: Thermal 
cauterization, a non-antigen-specific acute stimulation, was 
applied to the mouse corneal surface of either D6−/− mice or 
C57BL/6 WT mice to induce mobilization of inflammatory 
cells into corneal tissue. Under anesthesia, six light burns 
were applied to the central 50% of the cornea, using the tip 
of a hand-held thermal cautery (Aaron Medical Industries, St. 
Petersburg, FL). Afterward, bacitracin-neomycin-polymyxin 
(Vetropolycin; Dechra Veterinary Products, Overland Park, 
KS) ophthalmic ointment was applied. Corneas were excised 
7 days after being cauterized, harvested, and wholemount 
corneas were stained with CD11c to enumerate dendritic cell 
infiltration.
Statistical analysis: Statistical analyses including the Student 
t test were performed throughout the study, and are indicated 
in the respective figure legends. Error bars displayed in the 
figures were calculated from the standard error of the mean 
(±SEM). Kaplan–Meier analysis constructed survival curves 
and respective log-rank tests compared the rates of corneal 
graft survival. P values of <0.05 were considered significant.
RESULTS
D6 expression is required for phenotypic maturation of 
dendritic cells: Using flow cytometry, we examined D6 
expression in different leukocyte populations. D6 expression 
was detected in CD4+ and CD8+ T cells, CD11b+ leukocytes 
(primarily composed of macrophages), Gr-1high leukocytes 
(primarily comprised of neutrophils), and CD11c+ DCs. 
Interestingly, DCs were found to express the highest level of 
D6 among leukocyte subpopulations (Figure 1A), consistent 
with several previous reports [8-12,17].
Next, we hypothesized that the robust expression of D6 
chemokine receptor by DCs suggests important functionality 
in DCs. Antigen presentation and T-cell priming are two 
principal aspects of mature DC function, both enabled by 
upregulation of MHC II and costimulatory molecules. Thus, 
we next evaluated the function of the D6 chemokine receptor 
in phenotypic maturation (acquisition of high expression of 
Figure 1. D6 chemokine receptor 
expression by dendritic cells 
promotes their maturation. A: Flow 
cytometry analysis of whole spleen 
cells for D6 expression on CD4+ 
and CD8+ T cells, Gr-1high neutro-
phils, CD11b+ macrophages, and 
CD11c+ dendritic cells (DCs). The 
black line represents D6, the gray 
area represents the isotype control. 
D6 expression was higher in DCs 
compared to other leukocyte popu-
lations. B: Flow cytometry analysis 
of bone marrow–derived DCs for 
major histocompatibility complex 
(MHC) II and co-stimulatory 
molecules, CD40, CD80, and CD86 
(black area) versus the isotype control (gray area) is shown. Bone marrow–derived DCs from D6−/− and wild-type (WT; D6+/+) mice were 
analyzed 24 h after lipopolysaccharides (LPS; 100 ng/ml) treatment.
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MHC II and costimulatory factors) of DCs by comparing the 
maturation capacity of bone marrow–derived DCs from WT 
versus D6−/− mice in response to in vitro LPS stimulation. As 
expected, LPS elicited marked upregulation of MHC II (I-Ab) 
and costimulatory molecules, i.e., CD40, CD80, and CD86, in 
bone marrow–derived DCs isolated from WT mice. However, 
the bone marrow–derived DCs isolated from D6 chemokine 
receptor null mice demonstrated defective upregulation of all 
maturation markers assessed in our study (Figure 1B). Taken 
together, these findings demonstrate that DCs express high 
levels of D6 chemokine receptor, which is associated with 
higher phenotypic maturation.
D6 expression by dendritic cells promotes T-cell allosensi-
tization: Because maturation of DCs is critical to their role 
in priming alloreactive T cells, we next investigated whether 
D6-mediated maturation of DCs promotes T-cell allosensiti-
zation. A modified mixed leukocyte reaction assay was used, 
in which DCs from C57BL/6 WT or D6−/− mice were cocul-
tured with purified naïve T cells from allogeneic BALB/c 
mice, and subsequent T-cell proliferation was measured using 
a BrdU incorporation assay. Corroborating our phenotypic 
maturation observations, we found that DCs from D6−/− 
mice failed to induce proper alloreactive T-cell proliferation 
(p≤0.01), in contrast to DCs from WT mice (Figure 2A).
Next, we evaluated the role of D6 chemokine receptor 
expression by DCs on the alloreactive T-cell-mediated 
delayed-type hypersensitivity (DTH) reaction using the LAT 
assay [18]. Purified T cells from BALB/c mice primed against 
C57BL/6 were coinjected with WT or D6−/− DCs into the ear 
pinnae of the naïve BALB/c mice, and then the ear swelling 
was measured. Coinjection of T cells with DCs isolated 
from D6−/− mice elicited a significantly lower ear swelling 
compared to coinjection with WT DCs (p≤0.01) indicating 
that expression of D6 chemokine receptor is involved in the 
development of a DTH reaction (Figure 2B). These findings 
clearly suggested a functional role of D6 chemokine receptor 
expression in promoting DC phenotypic maturation and allo-
stimulatory capacity.
D6 expression promotes T-cell alloreactivity in the corneal 
transplant model: Based on our findings that D6 expression 
promotes the phenotypic and functional maturation of DCs, 
we hypothesize that D6 plays a key role in T-cell alloreac-
tivity and thus regulates the transplant outcome. We began 
our assessment by examining graft survival from C57BL/6 
WT and D6−/− hosts transplanted with either fully allodis-
parate BALB/c (I-Ad) corneas or syngeneic grafts (I-Ab). 
Surprisingly, the fate of corneal grafts from BALB/c mice to 
WT or D6−/− recipients was not significantly different. More-
over, D6−/− mice rejected even syngeneic grafts (Figure 3A). 
Since opacity-grading scales to evaluate the rejected grafts 
in D6−/− mice demonstrated similar outcomes even in synge-
neic mice, we next evaluated whether there are any differ-
ences in the generation of an alloreactive T-cell response in 
allotransplanted mice. Previously, we have reported a direct 
correlation between the frequency of CD4+/ interferon-γ+ 
(IFN-γ+) alloreactive T cells and immune rejection in the 
corneal transplant model [19,20]. Therefore, we harvested 
host lymph nodes from D6−/− or WT mice 3 weeks post-
transplantation and enumerated alloreactive T-cell frequency 
via flow cytometry. Alloreactive IFN-γ-producing CD4 T 
Figure 2. D6−/− dendritic cells 
generate impaired alloreactive 
T-cell responses. A: Mixed leuko-
cyte reaction (MLR) assay of bone 
marrow (BM)-derived mitomycin 
C–treated dendritic cells (DCs) 
from wild-type (WT; D6+/+) or D6−/− 
mice. Cells were cocultured with 
allodisparate T cells (BALB/c), and 
less T-cell proliferation was evalu-
ated using the bromodeoxyuridine 
(BrdU) assay. B: Delayed-type 
hypersensitivity (DTH) reaction in 
WT BALB/c mice receiving either 
splenic T cells from BALB/c mice 
(1×105) in 10 μl Hanks’ balanced salt solution alone or with 1×105 BM-derived DCs of either D6−/− or WT C57BL/6 mice. Cells were injected 
into the right pinna, and ear thickness was measured 48 h after injection. The experiment was performed twice, and representative data 
of one experiment are shown here; mean±standard error of the mean (SEM) of n=5 mice per group. P values are indicated comparing WT 
with D6−/− mice: **p≤0.01. 
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cells were significantly lower in allografted D6−/− recipients 
compared to the WT hosts (p≤0.05; Figure 3B). In addition, 
we have previously demonstrated that host T-cell proliferation 
is directly correlated with corneal allograft rejection [19]. In 
this study, we observed significantly decreased proliferation 
of T cells from transplanted D6−/− recipients compared to WT 
hosts using the BrdU incorporation assay (Figure 3C).
Host T cells were also tested for DTH responses using 
the LAT assay. Immune rejection is mediated by DTH, and 
Miyazaki et al. previously demonstrated a positive correla-
tion between DTH responses and corneal allograft rejection 
[21]. Purified T cells from D6−/− or WT mice 3 weeks post-
transplantation were coinjected with BALB/c APCs into the 
ear pinnae of the naïve WT C57BL/6 mice. We observed 
that the T cells from the transplanted D6−/− hosts elicited a 
significantly lower DTH response compared to the T cells 
from the WT hosts (Figure 3D). These data provide evidence 
that D6 expression in corneal grafted hosts plays a critical 
role in triggering T-cell alloreactivity.
Increased infiltration of CD11c+ cells in D6−/− inflamed 
corneas: We investigated whether D6−/− mice display an 
increased innate inflammatory response and used a standard-
ized model of cauterization-induced corneal inflammation. 
Seven days after cauterization, the corneas were stained for 
CD11c+ and enumerated using confocal microscopy. The 
inflamed corneas of the D6−/− mice showed a significantly 
increased number of CD11c+ cells compared to the inflamed 
corneas of the WT mice (p<0.05; Figure 4).
T cells from allografted D6−/− hosts have an impaired 
capacity to affect immune rejection following adoptive 
transfer: Though we did not detect a difference in corneal 
allograft rejection between the WT and D6−/− hosts, additional 
experiments that directly examined T-cell function (i.e., LAT 
and DTH assays) demonstrated impaired alloreactivity in 
Figure 3. Transplantation in 
D6−/− hosts leads to a reduction in 
alloreactive T-cell frequencies. 
A: BALB/c or C57BL/6 wild-type 
(WT) corneas were engrafted onto 
C57BL/6 D6−/− or WT (D6+/+) mice. 
Kaplan–Meier survival curves are 
plotted here (n=10 per group). B: 
Flow cytometry analysis of CD4+ 
interferon-γ+ (IFN-γ+) T cells of 
lymph nodes from D6−/− and WT 
hosts 3 weeks post-transplantation 
is shown. *P≤0.05 (n=10 per 
group). C: Proliferation assay of 
purified T cells from D6−/− or WT 
mice; T cells were isolated 3 weeks 
post-transplantation of BALB/c 
corneas onto C57BL/6 D6−/− or WT 
mice, and cocultured with BALB/c 
antigen presenting cells (APCs). 
Subsequent T-cell proliferation 
was measured with the bromode-
oxyuridine (BrdU) incorporation 
assay. D: Delayed-type hypersensi-
tivity (DTH) reaction in naïve WT 
C57BL/6 mice receiving purified T 
cells from D6−/− or WT allografted 
mice and BALB/c APC is shown. 
Cells were injected into the right 
pinna, and ear thickness was 
measured 48 h after injection. The 
experiment was performed twice, and representative data of one experiment are shown here; mean±standard error of the mean (SEM) of 
n=5 mice per group. P values indicate comparison of WT and D6−/−: *p≤0.05, **p≤0.01.
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D6−/− allografted hosts. Therefore, we adoptively transferred 
T cells from the allografted WT versus D6−/− hosts to the 
naïve wild-type C57BL/6 mice challenged with a fresh 
BALB/c corneal allograft. The allografted D6−/− T cells with 
reduced alloreactivity attenuated the immune rejection after 
adoptive transfer in C57BL/6 WT mice challenged with a 
fresh BALB/c cornea (p=0.015; Figure 5).
DISCUSSION
This study for the first time demonstrates the role of D6 
chemokine receptor expression by DCs in the development 
of alloimmune responses in transplanted hosts. We showed 
that D6 expression promotes DC maturation and is function-
ally relevant in enhancing alloimmune responses against the 
corneal graft demonstrated by adoptive transfer experiments.
The proresolving effect of D6 by chemokine scavenging 
has been well described. However, we demonstrated that 
D6 expression by DCs also has a proinflammatory effect by 
supporting T-cell-mediated alloimmunity. Studies supporting 
an immune amplifying function for D6 showed that 
D6−/− mice have an impaired ability to resolve a cutaneous 
inflammatory response after either topical application of the 
phorbol ester TPA or induction of granuloma development by 
subcutaneous injection of complete Freund’s adjuvant (CFA) 
[3,5-7]. Nevertheless, little work has been done to dissect this 
role on the level of lymphatic endothelial cells or leukocytic 
expression of D6. One attempt was done in an animal model 
of colitis, where D6-deficient mice showed enhanced suscep-
tibility to colitis [12]. However, restoration of D6 chemokine 
receptor expression in leukocytes and lymphatics through 
bone marrow transplantation demonstrated that the observed 
effect in this colitis mouse model is specifically related to the 
absence of D6 in the lymphatics, whereas leukocytes do not 
contribute to this phenotype.
The role of D6 in regulating the adaptive immune 
response was indirectly shown in alloimmune lung injury. 
Evaluation of D6−/− mice in the Th2 cell-dependent OVA 
model of lung inflammation showed reduced airway reac-
tivity as well as increased numbers of DCs and T cells in the 
inflamed lung compared to WT mice. In addition, D6−/− mice 
Figure 4. A larger number of 
dendritic cells infiltrate the cornea 
of D6−/− mice following inf lam-
mation induced by cauterization. 
A: Confocal microscopy of the 
cornea from wild-type (WT; D6+/+) 
and D6−/− mice 7 days post-cornea 
cauterization. The cornea was 
stained for CD11c (green) cells 
(magnification 40X). B: The bar 
chart represents the quantification 
of the CD11c-infiltrated cells in the 
D6−/− and WT corneas 7 days post-
cornea cauterization. *p≤0.05.
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demonstrated a rapid mortality subsequent to intranasal 
administration of low-dose Mycobacterium tuberculosis 
[5]. The conclusion of the study was that D6-deficient mice 
in this model displayed opposing effects on inflammation 
and airway reactivity, which resulted in a dysregulated, 
multiorgan, and systemic inflammatory response. Likewise, 
another study reported reduced airway hyperactivity to meth-
alcholine in D6−/− mice using a Th2 cell-mediated model of 
experimental allergic asthma [13]. Because T cells are key 
mediators in allergic asthma such observations may be in 
part due to an impaired allergen-reactive T-cell response 
in D6−/− mice. In accordance to our data, Liu et al. reported 
reduced pathology in D6−/− mice to experimental autoimmune 
encephalomyelitis (EAE) due to impaired autoreactive T cell 
response providing a direct connection between D6 expres-
sion and T-cell response [14].
Previously, several studies have implicated DC matura-
tion in mediating corneal alloimmunity [19,20,22]. Corre-
spondingly, several lines of evidence showed that DC matura-
tion, which we found to be positively regulated by D6 expres-
sion, plays a key role in promoting effector T-cell responses 
to the graft. The conclusion that D6 expression plays a role 
in phenotypic maturation of DCs is supported by our find-
ings that BMDCs from D6−/− mice have consistently impaired 
expression of MHC II, CD80, CD86, and CD40 upon in vitro 
LPS stimulation. Further, DCs from D6−/− mice showed 
impaired capacity to stimulate T-cell proliferation and DTH 
responses suggesting that D6-mediated functional maturation 
of DCs is directly linked to the capacity to stimulate T-cell 
responses. Thus, it is likely that impaired DC maturation in 
engrafted D6−/− hosts contributes to impaired T-cell response 
reflected in lowered alloreactive frequencies, mixed leuko-
cyte reaction and DTH responses, and decreased rejection.
Our findings are not in conflict with the current under-
standing that D6 is important in inflammatory resolution. 
Indeed, the opposing roles of D6 in inflammatory resolu-
tion and adaptive immune response activation may explain 
why corneal graft outcome in D6−/− and WT mice showed 
no significant difference in our study. In previous studies, 
cytokine expression analyses of corneal transplants have 
shown a biphasic pattern with no difference in the cyto-
kine expression pattern between syngeneic and allogeneic 
recipients in the early phase (3–9 days postoperatively) 
[23]. Analyzing inflamed corneas after cauterization injury 
revealed increased infiltration of innate non-allospecific cells 
in the cornea of D6−/− mice as early as 1 week after injury. 
We hypothesize that these innate immune cells express high 
levels of inflammatory cytokines that might cause graft 
failure in allografted D6−/− mice. Yamada et al. have shown 
that corneal allografts were rejected by infiltration of innate 
immune cells independently of IFN-γ/IL-17 producing CD4 
T cells, and the researchers proposed a still elusive pathway 
involved in graft rejection [24]. Likewise, we predict that a 
hyper-innate immune response in our transplanted D6−/− hosts 
may have caused the allograft to appear opaque in syngeneic 
hosts and thus be considered a failed transplant. We found 
that transplanted D6−/− hosts experience an approximate 
50% immune rejection rate (Figure 3A) as early as 1 week 
post-transplantation—a process that typically requires 2 to 3 
weeks to generate a prominent alloreactive T-cell response in 
corneal transplant [16,19,20].
In addition to the defective maturation of DCs, reduced 
migration of DCs from the grafted beds to lymph nodes is 
another potential factor that may have contributed to the 
blunted allosensitivity of T cells in D6−/− mice. It remains 
to be determined whether lymphatic vessel-expressed D6 
contributes to T-cell alloreactive responses by facilitating 
DC migration to the lymph nodes. This is, in fact, conceiv-
able since the neutralization of certain chemokines (e.g., 
CCR1–5) by D6 may consequently increase the reactivity 
to other chemokines that are not neutralized by D6, such as 
CCL19/21. CCL19/21 is important for the migration of DCs to 
the LN, where mature DCs elicit T-cell activation, and finally 
Figure 5. Immune rejection is attenuated after adoptive T-cell 
transfer from allografted D6−/−mice. Purified T cells from D6−/− or 
wild-type (WT; D6+/+) allografted mice were adoptively transferred 
into naïve wild-type C57BL/6 mice challenged with a fresh BALB/c 
cornea allograft. Graft survival is plotted in Kaplan–Meier curves 
(n=10 per group). P=0.015 D6-/- T cell vs. D6+/+ T cell group.
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promote alloreactivity. Whether D6 promotes transplant 
survival not only by regulating DC maturation but also DC 
mobilization to the LNs requires further investigation.
Based on our data, we conclude that host D6 expression 
is important in the induction of alloreactive T-cell responses 
and immune rejection. In addition, we demonstrated that D6 
expression by DCs plays a key role in their maturation and 
capacity to prime T cells. Further study is needed to clarify 
the connection between the proresolving effect of D6 in the 
lymphatic endothelium and its proinflammatory effect in DC 
maturation and on T-cell activation.
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